perimenopause and tirzepatide Body weight reduction in women treated with by reproductive stage: a post hoc analysis from the SURMOUNT program - Tchang - 2025 - Obesity Menopause: GLP-1 Drugs, Hormone Therapy
Description
It activates GLP-1
Most gastrointestinal side effects occur during dose escalation and reduce significantly over time
Tirzepatide is a synthetic peptide that mimics GIP and GLP-1
Tirzepatide activates both GLP-1 receptors and GIP receptors
Prediabetes: Studies in individuals with prediabetes and insulin resistance suggest that Tirzepatide may help prevent or delay the progression to type 2 diabetes
If you added 2 mL to a 10 mg vial instead of 1 mL, your concentration is now 5 mg/mL instead of 10 mg/mL
